Jane Street Group LLC Sells 28,460 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Jane Street Group LLC reduced its stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 60.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,881 shares of the company's stock after selling 28,460 shares during the period. Jane Street Group LLC owned approximately 0.07% of ZimVie worth $263,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ZIMV. Bank of New York Mellon Corp boosted its position in shares of ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock worth $1,404,000 after purchasing an additional 943 shares during the period. Rhumbline Advisers boosted its holdings in shares of ZimVie by 3.0% in the fourth quarter. Rhumbline Advisers now owns 45,214 shares of the company's stock valued at $631,000 after acquiring an additional 1,303 shares in the last quarter. SG Americas Securities LLC boosted its holdings in shares of ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after acquiring an additional 1,508 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock worth $266,000 after buying an additional 1,702 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in shares of ZimVie by 8.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,571 shares of the company's stock valued at $343,000 after buying an additional 1,852 shares during the last quarter. 95.63% of the stock is currently owned by institutional investors and hedge funds.

ZimVie Stock Performance

NASDAQ:ZIMV traded up $0.26 during trading hours on Friday, hitting $9.38. 82,743 shares of the company traded hands, compared to its average volume of 211,149. The stock has a market capitalization of $261.20 million, a price-to-earnings ratio of -0.72 and a beta of 2.10. ZimVie Inc. has a twelve month low of $8.15 and a twelve month high of $22.40. The firm has a 50-day moving average of $9.11 and a 200 day moving average of $11.95. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. The company had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.10 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. On average, analysts forecast that ZimVie Inc. will post 0.6 EPS for the current year.

Analysts Set New Price Targets

ZIMV has been the subject of a number of recent analyst reports. UBS Group lowered their price target on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a report on Thursday, May 15th. B. Riley started coverage on shares of ZimVie in a report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective for the company. Finally, Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.